Calypte, Beijing Marr Bio-Pharmaceutical Co. Ltd. deal

HIV acquired a 51% stake in Beijing Marr Bio-Pharmaceutical for an undisclosed sum. Marr Technologies BV, HIV's largest stockholder, owns the remaining 49% of Beijing Marr. HIV said the deal gives it ...